The Asia-Pacific oncolytic virus therapy market is estimated to grow at a CAGR of more than 14% during the forecast period. The Asia-Pacific region is estimated to be a potential market for oncolytic virus therapies due growing aging population coupled with the increasing prevalence and incidence of cancer across the major economies of the region. […]